Can cord stem cells calm cerebral palsy? a first test in kids

NCT ID NCT07763028

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This early-stage trial is testing whether a single injection of stem cells from umbilical cord tissue, given into the spinal fluid, is safe and practical for young children with cerebral palsy. The study will enroll about 7 children aged 2 to 5 with moderate to severe motor impairment. The main goals are to see if the procedure can be done without technical problems and to monitor for any side effects over six months, while also exploring any changes in motor function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
allogeneic umbilical cord tissue-derived mesenchymal stromal cells (UCT-MSCs)
What this could lead to
If safe and feasible, this could pave the way for larger studies exploring whether umbilical cord stem cells can ease symptoms or improve motor function in children with cerebral palsy.
What could go wrong
This is a very early, small pilot study focused on safety, not effectiveness. It may not show clear benefit, and there are risks like fever, infection, or neurological events from the procedure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CEREBRAL PALSY (CP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dr. Sardjito Hospital

    Yogyakarta, D.I. Yogyakarta, 55284, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.